Rationale: Quite recently, the presence of significant amounts of several emerging Dechlorane (Dec) flame retardants (FRs) was reported in environmental and biota samples, principally from Canada and China, but also from Europe. Several molecules were identified, e.g. Dec 602, 603, 604, Dechlorane Plus (DP), and Chlordene Plus (CP). Gas chromatography (GC) coupled to electron ionization (EI) high-resolution mass spectrometry (HRMS) is typically used for their measurement in various matrices based on hexachlorocyclopentadiene (HCCPD) fragment ions at m/z 271.8102/273.8072.

Methods: We investigated the use of GC with cryogenic zone compression and electron capture negative ionization time-of-flight mass spectrometry (CZC-GC/ECNI-TOFMS) to measure Dechlorane compounds at low levels in human serum. The TOFMS instrument provided a resolving power of 5000 (FWHM) with an acquisition rate of 25 Hz and was equipped with a specific low thermal emission filament, which allowed it to perform reproducibly in ECNI mode at ion source temperatures as low as 140°C, thus yielding a signal for the molecular ion cluster.

Results: The method provided comparable sensitivity to the GC/EI-SectorHRMS technique used in selected ion monitoring (SIM) mode, and specificity for the target Dechlorane compounds. The method was applied on human serum samples and quantification was performed for Dec 602, Dec 603, and CP, ranging from 0.1 to 10 ng/g lipid weight levels. The main drawbacks of the method are the high instrument detection limits (IDLs) obtained for DP and Dec 604. The method would benefit from even softer ionization and better ion transmission.

Conclusions: The main advantages of the present method are the selectivity, as detection is based on the molecular ion signal, and the use of good mass accuracy combined with isotopic distribution calculation for molecular formulae investigation of halogenated compounds. This methodology should facilitate the monitoring of emerging Dechlorane contaminants in future studies, and possibly extend the scope to untargeted emerging analogues. Copyright © 2016 John Wiley & Sons, Ltd.

Download full-text PDF

Source
http://dx.doi.org/10.1002/rcm.7745DOI Listing

Publication Analysis

Top Keywords

human serum
12
mass spectrometry
12
gas chromatography
8
chromatography coupled
8
coupled electron
8
electron capture
8
capture negative
8
negative ionization
8
ionization time-of-flight
8
time-of-flight mass
8

Similar Publications

Chemerin loss-of-function attenuates glucagon-like peptide-1 secretion in exercised obese mice.

Diabetes Obes Metab

January 2025

School of Exercise and Health, Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport, Shanghai, China.

Aims: To investigate the role of chemerin reduction in mediating exercise-induced Glucagon-like peptide-1 (GLP-1) secretion and the amelioration of pancreatic β-cell function in obesity.

Materials And Methods: Obesity models were established using wild-type and chemerin systemic knockout mice, followed by 8 weeks of moderate-intensity continuous aerobic exercise training. Serum chemerin levels, GLP-1 synthesis, glucose tolerance, pancreatic β-cell function, structure, and apoptosis were assessed.

View Article and Find Full Text PDF

Background: YYD601 is a new dual delayed-release formulation of esomeprazole, developed to enhance plasma exposure and prolong the duration of acid suppression.

Purpose: This study aimed to evaluate the safety, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of YYD601 20 mg following single and multiple oral administrations in healthy, fasting adult Koreans, and to compare these outcomes to those of the conventional esomeprazole 20 mg capsule.

Methods: A randomized, open-label, two-period crossover study was conducted in 28 participants, who were divided into two treatment groups: one group received YYD601 20 mg, and the other received conventional esomeprazole 20 mg, once daily for five consecutive days.

View Article and Find Full Text PDF

Staphylococcus aureus prosthetic joint infections (PJIs) are broadly considered incurable, and clinical diagnostics that guide conservative vs. aggressive surgical treatments do not exist. Multi-omics studies in a humanized NSG-SGM3 BLT mouse model demonstrate human T cells: 1) are remarkably heterogenous in gene expression and numbers, and 2) exist as a mixed population of activated, progenitor-exhausted, and terminally-exhausted Th1/Th17 cells with increased expression of immune checkpoint proteins (LAG3, TIM-3).

View Article and Find Full Text PDF

Oncogenic Osteomalacia as the Initial Presentation of Pleural Epithelioid Hemangioendothelioma: A Case Report.

Cureus

December 2024

Department of Medicine, Division of Endocrinology and Metabolism, King Abdulaziz Medical City, Riyadh, SAU.

Epithelioid hemangioendothelioma (EHE) is a rare form of vascular neoplasm that can manifest with various symptoms or be discovered incidentally in asymptomatic patients. In this report, we describe a case of a 56-year-old male who presented with progressive lower limb weakness over four years. The evaluation revealed severe hypophosphatemia, an inappropriately normal fibroblast growth factor 23 C-terminal (cFGF-23) level, and a 30 x 20 mm hypermetabolic right pleural mass, which was subsequently proven to be EHE.

View Article and Find Full Text PDF

Typical renal involvement of antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is pauci-immune glomerulonephritis that presents clinically as rapidly progressive renal failure (RPRF). Here, we report an unusual presentation of myeloperoxidase (MPO)-specific ANCA with isolated involvement of the tubulointerstitium in the form of peritubular capillaritis as the sole lesion without any involvement of the glomerulus. A 52-year-old woman with no previous comorbidities presented with nonspecific symptoms such as fatigue, dysuria, and nausea for two months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!